Angela Hwang
President at HOSPIRA, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Angela Hwang is an Independent Director at United Parcel Service, Inc. She is also a Director at The Pfizer Foundation, Inc. and the European Federation of Pharmaceutical Industries & Assns.
Additionally, Ms. Hwang is the President of Hospira, Inc. In her former positions, she served as the Chief Commercial Officer at Pfizer Inc. from 1997 to 2023 and as the Global President at Pfizer Essential Health from 2016 to 2019.
Ms. Hwang holds an MBA from Cornell University and an undergraduate degree from the University of Cape Town.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PFIZER INC.
0.00% | 2023-05-09 | 67,161 ( 0.00% ) | 2 M $ | 2024-04-29 |
2024-05-01 | 4,268 ( 0.00% ) | 629 061 $ | 2024-04-29 |
Angela Hwang active positions
Companies | Position | Start |
---|---|---|
HOSPIRA, INC. | President | - |
UNITED PARCEL SERVICE INC. | Director/Board Member | 2020-07-12 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Director/Board Member | - |
The Pfizer Foundation, Inc.
The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost. | Director/Board Member | - |
Former positions of Angela Hwang
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 2023-12-14 |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Essential Health is an American company that manufactures pharmaceutical products. | President | 2019-11-30 |
Training of Angela Hwang
University of Cape Town | Undergraduate Degree |
Cornell University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
UNITED PARCEL SERVICE INC. | Transportation |
Private companies | 4 |
---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
The Pfizer Foundation, Inc.
The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost. | Commercial Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Essential Health is an American company that manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Angela Hwang